Due to network maintenance at the University of Basel, the SWISS-MODEL website will be interrupted this weekend between 07:00 CET Saturday 17th May and 23:55 CET Sunday 18th May.

Multiple Assemblies exist for SMTL entry 6fdi
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-226; X-RAY DIFFRACTION 1.90 Å

SMTL ID
6fdi.1
Ligands
ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; DI(HYDROXYETHYL)ETHER; 1-[2-[4-[(4~{a}~{S},8~{a}~{R})-4-(3,4-dimethoxyphenyl)-1-oxidanylidene-4~{a},5,8,8~{a}-tetrahydrophthalazin-2-yl]piperi din-1-yl]-2-oxidanylidene-ethyl]-4,4-dimethyl-piperidine-2,6-dione
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer
SMTL ID
6fdi.2
Ligands
ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; DI(HYDROXYETHYL)ETHER; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; 1-[2-[4-[(4~{a}~{S},8~{a}~{R})-4-(3,4-dimethoxyphenyl)-1-oxidanylidene-4~{a},5,8,8~{a}-tetrahydrophthalazin-2-yl]piperi din-1-yl]-2-oxidanylidene-ethyl]-4,4-dimethyl-piperidine-2,6-dione
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer
SMTL ID
6fdi.3
Ligands
1,2-ETHANEDIOL; ZINC ION; MAGNESIUM ION; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; 1-[2-[4-[(4~{a}~{S},8~{a}~{R})-4-(3,4-dimethoxyphenyl)-1-oxidanylidene-4~{a},5,8,8~{a}-tetrahydrophthalazin-2-yl]piperi din-1-yl]-2-oxidanylidene-ethyl]-4,4-dimethyl-piperidine-2,6-dione
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer
SMTL ID
6fdi.4
Ligands
1,2-ETHANEDIOL; ZINC ION; MAGNESIUM ION; DI(HYDROXYETHYL)ETHER; 1-[2-[4-[(4~{a}~{S},8~{a}~{R})-4-(3,4-dimethoxyphenyl)-1-oxidanylidene-4~{a},5,8,8~{a}-tetrahydrophthalazin-2-yl]piperi din-1-yl]-2-oxidanylidene-ethyl]-4,4-dimethyl-piperidine-2,6-dione; TETRAETHYLENE GLYCOL
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer